Insights

Biotech Therapeutics Focus Axial Therapeutics specializes in developing gut-restricted, small molecule therapeutics for CNS disorders, presenting sales opportunities to healthcare providers and institutions seeking innovative treatment options for neurodegenerative diseases.

Innovative Drug Development Platform With a unique expertise in the gut-brain axis, Axial Therapeutics utilizes cutting-edge technologies such as React, Google Analytics, and Microsoft tools in its drug development process. This presents an opportunity for technology providers to offer complementary solutions or collaborations.

Funding and Growth Potential Having raised significant funding of $37M and with a revenue range of $0 - 10M, Axial Therapeutics is poised for growth. Sales professionals could target the company for partnership opportunities, as they may seek new strategic alliances to fuel their expansion.

Market Gap Opportunity In a niche market focusing on gut-brain therapeutics, Axial Therapeutics is positioned uniquely. Sales teams should explore partnerships or collaborations to bridge any gaps in the market and leverage the company's innovative solutions.

Competitive Positioning and Differentiation Compared to larger biotech companies, Axial Therapeutics stands out for its specialized focus and innovative approach. Sales representatives could highlight these unique selling points to target customers looking for more personalized and advanced solutions in CNS disorder treatment.

Axial Therapeutics, Inc. Tech Stack

Axial Therapeutics, Inc. uses 8 technology products and services including Google Analytics Enhanced eCommerce, React, jQuery, and more. Explore Axial Therapeutics, Inc.'s tech stack below.

  • Google Analytics Enhanced eCommerce
    Analytics
  • React
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Module Federation
    Miscellaneous
  • HTTP/3
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Priority Hints
    Performance
  • HSTS
    Security

Media & News

Axial Therapeutics, Inc.'s Email Address Formats

Axial Therapeutics, Inc. uses at least 2 format(s):
Axial Therapeutics, Inc. Email FormatsExamplePercentage
First@axialbiotherapeutics.comJohn@axialbiotherapeutics.com
59%
FLast@axialbiotherapeutics.comJDoe@axialbiotherapeutics.com
19%
FirstLas@axialbiotherapeutics.comJohnDoe@axialbiotherapeutics.com
6%
LastFir@axialbiotherapeutics.comDoeJoh@axialbiotherapeutics.com
7%
First-Last@axialbiotherapeutics.comJohn-Doe@axialbiotherapeutics.com
6%
Middle@axialbiotherapeutics.comMichael@axialbiotherapeutics.com
3%
First@axialtx.comJohn@axialtx.com
82%
FirstLast@axialtx.comJohnDoe@axialtx.com
12%
FLast@axialtx.comJDoe@axialtx.com
6%

Frequently Asked Questions

Where is Axial Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Axial Therapeutics, Inc.'s main headquarters is located at 9 Fourth Avenue Waltham, MA 02451 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Axial Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Axial Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Axial Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Axial Therapeutics, Inc.'s official website is axialtx.com and has social profiles on LinkedIn.

How much revenue does Axial Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of October 2024, Axial Therapeutics, Inc.'s annual revenue reached $3.8M.

What is Axial Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Axial Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Axial Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2024, Axial Therapeutics, Inc. has approximately 12 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: A. S. C.Vice President Development: S. C.Executive Assistant To Co-Founder, CEO And Director: S. D.. Explore Axial Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Axial Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Axial Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Axial Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Axial Therapeutics, Inc.'s tech stack includes Google Analytics Enhanced eCommerceReactjQueryModule FederationHTTP/3MicrosoftPriority HintsHSTS.

What is Axial Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Axial Therapeutics, Inc.'s email format typically follows the pattern of . Find more Axial Therapeutics, Inc. email formats with LeadIQ.

How much funding has Axial Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2024, Axial Therapeutics, Inc. has raised $37M in funding. The last funding round occurred on Oct 13, 2021 for $37M.

When was Axial Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Axial Therapeutics, Inc. was founded in 2016.
Axial Therapeutics, Inc.

Axial Therapeutics, Inc.

Biotechnology ResearchMassachusetts, United States11-50 Employees

Axial Therapeutics™ is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders. The company is leveraging its expertise in the gut-brain axis and its unique drug development platform to advance novel therapies that have the potential to transform the treatment paradigm in neurodegenerative diseases.

Section iconCompany Overview

Headquarters
9 Fourth Avenue Waltham, MA 02451 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $37M

    Axial Therapeutics, Inc. has raised a total of $37M of funding over 5 rounds. Their latest funding round was raised on Oct 13, 2021 in the amount of $37M.

  • $10M

    Axial Therapeutics, Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $37M

    Axial Therapeutics, Inc. has raised a total of $37M of funding over 5 rounds. Their latest funding round was raised on Oct 13, 2021 in the amount of $37M.

  • $10M

    Axial Therapeutics, Inc.'s revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.